Cancer cells regularly harness CTL antigen 4 (CTLA-4 or CD152) and programmed cell death-1 (PD-1 or CD279) immune-checking molecules to escape detection and elimination by the immune system [34,35,36,37]. Here, CTLA4 is linked to cancer.